NEW YORK (GenomeWeb News) – MDxHealth today reported that its first-half 2012 revenues climbed 43 percent on a sharp uptick in commercial revenues.

The Liege, Belgium-based molecular diagnostics firm reported total revenues of €2 million ($2.5 million) for the six-month period ended June 30, compared to revenues of €1.4 million for the first half of 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.